title: Successful closure of residual leak following LARIAT procedure in a patient with high risk of stroke and hemorrhage.
abstract: Percutaneous left atrial appendage suture ligation with the LARIAT® device (Sentre HEART, Redwood City, CA) was successfully performed on an 84-year-old woman with non-valvular atrial fibrillation who developed intracranial hemorrhage on warfarin. However, a large gap developed at follow-up precluding warfarin cessation. To the best of our knowledge, this case report represents the first description of the use of a Gore® Helex® Septal Occluder (W. L. Gore and Associates, Newark, Delaware) as a novel approach to close a gap following percutaneous LAA suture ligation.
authors.forename: Wen-Loong
authors.initials: WL
authors.lastname: Yeow
authors.forename: Takashi
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Saibal
authors.initials: S
authors.lastname: Kar
mesh_terms: D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D020517:Atrial Appendage / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000601:surgery*; D006348:Cardiac Surgical Procedures / Q000295:instrumentation* / Q000379:methods; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D017548:Echocardiography, Transesophageal; D005260:Female; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D008026:Ligation; D013536:Suture Techniques; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D014859:Warfarin